Wilmington, DE, June 28, 2023—Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it closed the acquisition of Novastep®, a subsidiary of Amplitude Surgical SA (Paris: AMPLI), and global developer of clinically proven foot and ankle solutions. Novastep strengthens Enovis’ position in the growing bunion segment with its best-in-class MIS bunion
/EINPresswire.com/ — Novastep Inc., and its affiliates (“Novastep”), today announced the commercial launch of the Pecaplasty® System, a guided instrumentation and implant platform for percutaneous bunion correction. The Pecaplasty® System delivers a long-awaited solution, designed for precise realignment, accurate stabilization, and reproducible outcomes. In 2019, Novastep launched their minimally invasive (MIS) PECA implants, combined with specialized instruments,
/ EINPresswire.com / – Novastep Inc., and its affiliates (“Novastep”), today announced the full market release of its Presslock® Compression Locking universal fusion plates, (the “Presslock Plates”). The Presslock Plates further expand the capabilities of the Airlock® Forefoot/Midfoot Plating System by allowing the usage of axially stable locking screws within the compression slots of the plates. These slots provide an
(GLOBE NEWSWIRE) — Novastep Inc., and its affiliates (“Novastep” or the “Company”), a global medical technologies company specializing in foot and ankle surgery, today announced it has signed an exclusive distribution and education agreement with Carbon22, a GLW, Inc. company (“Carbon22”). Carbon22 is a start-up, musculoskeletal company, comprised of a consortium of orthopedic and podiatric surgeons. The
(GLOBE NEWSWIRE) — Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical technologies company specializing in foot and ankle surgery, today announced the U.S. launch and full commercial availability of the PECA® minimally invasive surgical (MIS) implant system for mild to severe hallux valgus (bunion) deformities. The first commercial PECA® cases were
A global medical technologies company specializing in the foot and ankle, has announced an expansion of their cleanSTART® Delivery Platform with the launch of their airlockGO® product line.
June 24, 2016 (GLOBE NEWSWIRE) — Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical technologies company specializing in the foot and ankle, today announced the launch of an innovative range of patent pending, cleanSTART sterile packaged, single-use instruments kits. The kits are engineered to reduce cross contamination risks and processing costs
July 14, 2015 (GLOBE NEWSWIRE) — Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical device company specializing in the foot and ankle, today announced the general availability of their cleanSTART® packaging and delivery technology in the U.S. market. The cleanSTART platform provides hospitals and surgery centers with a systematized approach towards
June 24, 2015 (GLOBE NEWSWIRE) — Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical device company specializing in the foot and ankle, today announced the U.S. launch of its Airlock MTP Locking Plate System. The first case in North America was conducted by Aaron J. Shemenski, DPM, FACFAS at Morton Hospital
